Production (Stage)
Serina Therapeutics, Inc.
SER
$5.75
$0.01430.25%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.27M | 3.67M | 3.19M | 6.06M | 8.71M |
| Total Receivables | -- | -- | 14.00K | 51.00K | 65.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.34M | 1.93M | 2.08M | 2.80M | 166.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 150.00K | 77.00K | 143.00K | -- | -- |
| Total Current Assets | 5.75M | 5.68M | 5.42M | 8.92M | 8.94M |
|
|
|||||
| Total Current Assets | 5.75M | 5.68M | 5.42M | 8.92M | 8.94M |
| Net Property, Plant & Equipment | 977.00K | 1.05M | 1.12M | 1.20M | 1.30M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 509.00K | 541.00K | 574.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 383.00K | 50.00K | 50.00K |
| Total Assets | 6.73M | 6.72M | 7.44M | 10.71M | 10.86M |
|
|
|||||
| Total Accounts Payable | 1.19M | 744.00K | 1.70M | 1.20M | 2.61M |
| Total Accrued Expenses | 979.00K | 1.43M | 1.16M | 769.00K | 1.41M |
| Short-term Debt | -- | -- | 10.46M | 10.45M | 9.75M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 185.00K | 193.00K | 198.00K | 211.00K | 231.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 5.00K | 69.00K |
| Total Other Current Liabilities | -- | -- | -- | 5.00K | 69.00K |
| Total Current Liabilities | 2.35M | 2.37M | 13.51M | 12.63M | 14.06M |
|
|
|||||
| Total Current Liabilities | 2.35M | 2.37M | 13.51M | 12.63M | 14.06M |
| Long-Term Debt | -- | -- | 693.00K | 693.00K | 693.00K |
| Short-term Debt | -- | -- | 10.46M | 10.45M | 9.75M |
| Capital Leases | 227.00K | 268.00K | 312.00K | 362.00K | 413.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.59M | 3.58M | 6.74M | 13.41M | -- |
| Total Liabilities | 5.17M | 6.22M | 21.26M | 27.10M | 15.17M |
|
|
|||||
| Common Stock & APIC | 50.83M | 44.96M | 8.00M | 6.82M | 1.13M |
| Retained Earnings | -49.13M | -44.32M | -21.78M | -23.19M | -5.44M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 1.70M | 641.00K | -13.77M | -16.36M | -4.31M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.70M | 641.00K | -13.77M | -16.36M | -4.31M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -142.00K | -133.00K | -54.00K | -30.00K | -- |
| Total Equity | 1.56M | 508.00K | -13.83M | -16.39M | -4.31M |
|
|
|||||